These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3333881)

  • 61. [Effect of S-oxidation on the anticoagulant action of warfarin thioanalogs].
    Rehse K; Rüther D
    Arch Pharm (Weinheim); 1984 Feb; 317(2):163-7. PubMed ID: 6732444
    [No Abstract]   [Full Text] [Related]  

  • 62. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
    Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
    Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Oral anticoagulant therapy with special reference to the influence of food and drug interactions].
    Aosaki M
    Kokyu To Junkan; 1991 Aug; 39(8):779-88. PubMed ID: 1681576
    [No Abstract]   [Full Text] [Related]  

  • 65. Menthol reduces the anticoagulant effect of warfarin by inducing cytochrome P450 2C expression.
    Hoshino M; Ikarashi N; Tsukui M; Kurokawa A; Naito R; Suzuki M; Yokobori K; Ochiai T; Ishii M; Kusunoki Y; Kon R; Ochiai W; Wakui N; Machida Y; Sugiyama K
    Eur J Pharm Sci; 2014 Jun; 56():92-101. PubMed ID: 24594507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man.
    Levy G; Mager DE; Cheung WK; Jusko WJ
    J Pharm Sci; 2003 May; 92(5):985-94. PubMed ID: 12712418
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Warfarin and vitamin K.
    Suttie JW
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI16-8. PubMed ID: 2191810
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
    J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of warfarin resistance. Warfarin and the metabolism of vitamin K 1 .
    Bell RG; Caldwell PT
    Biochemistry; 1973 Apr; 12(9):1759-62. PubMed ID: 4699235
    [No Abstract]   [Full Text] [Related]  

  • 70. The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats.
    Guo C; Xue S; Zheng X; Lu Y; Zhao D; Chen X; Li N
    Xenobiotica; 2018 Apr; 48(4):400-406. PubMed ID: 28287050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.
    Shetty HG; Fennerty AG; Routledge PA
    Clin Pharmacokinet; 1989 Apr; 16(4):238-53. PubMed ID: 2656051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats.
    Bell RG; Caldwell PT; Holm EE
    Biochem Pharmacol; 1976 May; 25(9):1067-70. PubMed ID: 1267852
    [No Abstract]   [Full Text] [Related]  

  • 73. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin].
    Yamamoto T; Hasegawa K; Onoda M; Tanaka K
    Yakugaku Zasshi; 2016; 136(6):905-11. PubMed ID: 27252068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Warfarin resistance and vitamin K requirement in the rat.
    Greaves JH; Ayres P
    Lab Anim; 1973 May; 7(2):141-8. PubMed ID: 4712304
    [No Abstract]   [Full Text] [Related]  

  • 76. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Warfarin resistance.
    Sinxadi P; Blockman M
    Cardiovasc J Afr; 2008; 19(4):215-7. PubMed ID: 18776969
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats.
    Leck JB; Park BK
    Biochem Pharmacol; 1981 Jan; 30(2):123-8. PubMed ID: 7236301
    [No Abstract]   [Full Text] [Related]  

  • 79. Serum pharmacokinetics and coagulation aberration induced by sodium dehydroacetate in male and female Wistar rats.
    Zhang Y; Ying D; Liu H; Yu Z; Han L; Xie J; Xie Y
    Sci Rep; 2017 Apr; 7():46210. PubMed ID: 28387309
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toxicity reference values for chlorophacinone and their application for assessing anticoagulant rodenticide risk to raptors.
    Rattner BA; Horak KE; Lazarus RS; Schultz SL; Knowles S; Abbo BG; Volker SF
    Ecotoxicology; 2015 May; 24(4):720-34. PubMed ID: 25600128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.